National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Interventional Fluoroscopy: Reducing Radiation Risks for Patients and Staff
    Posted: 04/18/2005



Introduction






Increasing use and complexity






Determinants of radiation dose






Radiation risks






Strategies to optimize radiation exposure






Physician-patient communication before and after






Dosimetry records and follow up






Education and training






Conclusion






Reference list



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Conclusion

Interventional fluoroscopy is an increasingly important and valuable tool for treating disease, but it is not without risk. It is important for the health care community, manufacturers and regulators to work together to optimize patient radiation dose. Physicians must continuously think about optimizing radiation dose to the patient. Used prudently and optimally, interventional fluoroscopy is one of the valuable treatment modalities for a wide variety of diseases and disorders.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov